Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
• Product Development Risk is <strong>Solvay</strong>’s exposure to failure to develop new products and technologies or scale<br />
up a process. <strong>Solvay</strong>’s operating results depend, among other factors, on the innovation and development of<br />
commercially viable new products and production technologies. Because of the lengthy development process,<br />
technological challenges and intense competition, <strong>Solvay</strong> cannot ensure that the products it develops will become<br />
market-ready or achieve commercial success. If <strong>Solvay</strong> is unsuccessful in developing new products and<br />
production processes in the future, its competitive position and operating results will be harmed.<br />
Mitigation efforts<br />
<strong>Solvay</strong> <strong>Solvay</strong> devotes substantial resources to Research and Development. <strong>Solvay</strong> continuously improves<br />
the competitiveness of its essential products over the long term, through technological improvements and<br />
innovation. Innovation is the cornerstone of the Group’s strategy, and <strong>Solvay</strong> considers that managing<br />
the challenges related to product development is more about opportunity than risk for the company.<br />
Management of R&D by programs and projects fully in line with <strong>Solvay</strong>’s strategy enhances R&D performance and<br />
reduces the risk of failure.<br />
Management by projects, with a conceptual and operational roadmap for moving a new product project from idea<br />
to launch, also ensures that resources are used in an optimal way.<br />
Participation in venture capital funds allows <strong>Solvay</strong> to remain engaged at the forefront of emerging businesses<br />
such as alternative renewable energies and organic electronics.<br />
<strong>Solvay</strong> launched a dynamic innovation program at corporate level nine years ago, covering its main fields<br />
of activity, including R&D.<br />
7. Risk to People<br />
Risk to People is the exposure of employees, contractors and the public to adverse effects from <strong>Solvay</strong>’s activities<br />
and products, for example from plant processes or from transportation of hazardous chemicals. A major accident<br />
can injure people or lead to the temporary closing of a plant and ultimately expose <strong>Solvay</strong> to significant liabilities.<br />
Mitigation efforts<br />
<strong>Solvay</strong> considers the safety and health of people key aspects in the management of its activities. The Group has<br />
consistently developed and implemented stringent safety programs. Related policies and risk control programs apply<br />
to all production units and other facilities, including to contractors and newly acquired plants.<br />
The risk of hazardous chemicals transportation is reduced by mapping and minimizing transport routes and by<br />
the operation of integrated production units, which do not require the transportation of intermediate goods.<br />
<strong>Solvay</strong> follows recommendations of associations like Eurochlor and programs like Responsible Care ® .<br />
8. Environmental Risk<br />
Environmental Risk is <strong>Solvay</strong>’s exposure stemming from the accidental release of a chemical substance following<br />
a plant equipment failure, a transport accident or production problems resulting in exceeding permitted emission levels.<br />
<strong>Solvay</strong> operates manufacturing plants in many regions. Like most industrial equipment, this may create<br />
environmental risks through the accidental release of chemicals into the environment. Around 30 sites are covered<br />
by regulations dealing with major risks. Like most other industrial companies, <strong>Solvay</strong> has to manage and remediate<br />
historical soil contamination at some of its sites.<br />
Financial<br />
111<br />
<strong>Solvay</strong> Global Annual Report 2007